Hepatic Disease in Patients With HIV
Summary
- Interferon alfa-2a therapy may be relatively ineffective for the treatment of HBV in persons coinfected with HIV[Di Martino 2000; Di Martino 2002]
- Peginterferon alfa-2a is currently recommended by the AASLD (Management Guidelines)[AASLD HBV] and by EASL (Management Guidelines)[EASL HBV] as one of the options for first-line HBV therapy
- Peginterferon alfa-2a appears to be more effective than standard interferon-alfa-2b for the treatment of chronic HBV infection
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content